On March 14, 2024, InnoCan Pharma Corporation closed the transaction. The company has now issued 7,952,840 units at a price of CAD 0.25 per for the gross proceeds of CAD 1,988,210.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 CAD | 0.00% | +5.56% | -8.06% |
1st Jan change | Capi. | |
---|---|---|
-8.06% | 58.29M | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+16.13% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- INNO Stock
- News InnoCan Pharma Corporation
- InnoCan Pharma Corporation announced that it has received CAD 1.98821 million in funding